Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis

Rheumatology International

Volumn 30, Issue 11, 2010, Pages 1411-1416

  Azevedo, V F ^b   Pecoits Filho, R ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b NONE

Author keywords

Ankylosing Spondylitis; Arterial stiffness; Atherosclerosis; Biomarkers; Cardiovascular disease; Endothelial activation; Endothelial dysfunction; Inflammation; Spondylarthropathies

Indexed keywords

BIOLOGICAL MARKER;

ANKYLOSING SPONDYLITIS; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SACROILIITIS; SYSTEMIC DISEASE; VASODILATATION;

ATHEROSCLEROSIS; COMORBIDITY; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 77957563649     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-010-1416-3     Document Type: Review

References (64)

1. MJ Peters IE van der Horst-Bruinsma BA Dijkmans MT Nurmohamed 2004 Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis Semin Arthritis Rheum 34 585 592 10.1016/j.semarthrit.2004.07.010 15609262 (Pubitemid 39643120)
2. EP Radford R Doll PG Smith 1977 Mortality among patients with ankylosing spondylitis not given X-ray therapy N Engl J Med 297 572 576 10.1056/NEJM197709152971103 1:STN:280:DyaE2s3jt1GqtQ%3D%3D 887115 (Pubitemid 8197336)
3. RE Kaprove AH Little DC Graham, et al. 1980 Ankylosing spondylitis: survival in men with and without radiotherapy Arthritis Rheum 23 57 61 10.1002/art.1780230110 1:STN:280:DyaL3c7gvFersg%3D%3D 7352944 (Pubitemid 10214770)
4. SC Darby R Doll SK Gill, et al. 1987 Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis Br J Cancer 55 179 190 1:STN:280:DyaL2s7ivVOktQ%3D%3D 3814487
5. K Lehtinen 1993 Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis Ann Rheum Dis 52 174 176 10.1136/ard.52.3.174 1:STN:280:DyaK3s3kvFaqsQ%3D%3D 8484668
6. JE Salmon MJ Roman 2008 Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus Am J Med 121 10 Suppl 1 S3 S8 10.1016/j.amjmed.2008.06.010 18926167
7. Pereira IA, Borba EF (2008) The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. Swiss Med Wkly 138(37-38):534-539
8. N Sattar DW McCarey H Capell IB McInnes 2003 Explaining how ''high-grade'' systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2957 2963 10.1161/01.CIR.0000099844.31524.05 14676136 (Pubitemid 37553561)
9. R Ross 1999 Atherosclerosis- an inflammatory disease N Engl J Med 340 115 126 10.1056/NEJM199901143400207 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D 9887164 (Pubitemid 29054847)
10. G Wick M Knoflach Q Xu 2004 Autoimmune and inflammatory mechanisms in atherosclerosis Ann Rev Immunol 22 361 403 10.1146/annurev.immunol.22.012703. 104644 1:CAS:528:DC%2BD2cXktlOgs7Y%3D (Pubitemid 38680427)
11. A Doria Y Sherer PT Meroni Y Schoenfeld 2005 Inflammation and accelerated atherosclerosis. Basic mechanisms Rheum Dis N Am 31 355 362 10.1016/j.rdc.2005.01.006 (Pubitemid 40732493)
12. K Maksimowicz-McKinnon DL Bhatt LH Calabrese 2004 Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers Curr Opin Rheumatol 16 1 18 24 10.1097/00002281-200401000-00005 1:CAS:528: DC%2BD3sXpsl2nsLk%3D 14673384 (Pubitemid 38041394)
13. BH Hahn J Grossman W Chen M McMahon 2007 The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia J Autoimmun 28 2-3 69 75 10.1016/j.jaut.2007.02.004 1:CAS:528:DC%2BD2sXkvFOlsLc%3D 17433865 (Pubitemid 46670686)
14. C Han DW Robinson Jr MV Hackett LC Paramore KH Fraeman MV Bala 2006 Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis J Rheumatol 33 11 2167 2172 16981296
15. AR Sharrett CM Ballantyne SA Coady, et al. 2001 Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study Circulation 104 1108 1113 10.1161/hc3501.095214 1:CAS:528:DC%2BD3MXotlWgur0%3D 11535564
16. RS Rosenson 2005 Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities Curr Opin Cardiol 20 313 317 10.1097/01.hco.0000168534.15085.5d 15956829 (Pubitemid 40896371)
17. DJ Rader 2002 High density lipoproteins and atherosclerosis Am J Cardiol 90 suppl i62 i70 10.1016/S0002-9149(02)02635-8
18. S Rossner 1978 Further studies on serum lipoproteins in connective tissue diseases Atherosclerosis 31 93 99 10.1016/0021-9150(78)90041-2 1:CAS:528:DyaE1cXlvFCrurY%3D 213090
19. J Joven J Rubies-Prat MR Ras M de la Figuera E Lience S Masdeu 1984 High density lipoprotein cholesterol subfractions and apolipoprotein A-I in patients with rheumatoid arthritis and ankylosing spondylitis Arhtritis Rheum 27 1199 2000 10.1002/art.1780271021 1:STN:280:DyaL2M%2Fit1yqug%3D%3D
20. H Divecha N Sattar A Rumley L Cherry GDO Lowe R Sturrock 2005 Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation Clin Sci (Lond) 109 2 171 176 10.1042/CS20040326 1:CAS:528:DC%2BD2MXmsFCiurY%3D (Pubitemid 41117300)
21. D Malesci A Niglio GA Mennillo R Buono G Valentini G La Montagna 2007 High prevalence of metabolic syndrome in patients with ankylosing spondylitis Clin Rheumatol 26 5 710 714 10.1007/s10067-006-0380-5 16933103 (Pubitemid 46554077)
22. VP van Halm JC van Denderen MJ Peters JW Twisk M van der Paardt IE van der Horst-Bruinsma RJ van de Stadt MH de Koning BA Dijkmans MT Nurmohamed 2006 Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis Ann Rheum Dis 65 11 1473 1477 10.1136/ard.2005.050443 16644785 (Pubitemid 44629125)
23. AT Masi JC Aldag PC Mohan TSR Murugan 1999 Determinants of significantly lower serum total cholesterol levels in ankylosing spondylitis patients than age-, gender-, and medical service-matched control patients: results of multivariate analysis Arthritis Rheum 42 Suppl S300
24. AT Masi JC Aldag PC Mohan TSR Murugan 2000 Significantly lower serum triglyceride levels in ankylosing spondylitis patients than age-, gender-, and medical service-matched controls: results of multivariate analysis Arthritis Rheum 43 Suppl S104
25. D Burger JM Dayer 2002 High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev 1 111 117 10.1016/S1568-9972(01)00018-0 1:CAS:528:DC%2BD38Xlt1Clsbs%3D 12849067 (Pubitemid 38367434)
26. J Hulthe B Fagerberg 2002 Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study) Arterioscler Thromb Vasc Biol 22 1162 1167 10.1161/01.ATV.0000021150.63480.CD 1:CAS:528:DC%2BD38XlsFSgsrk%3D 12117732 (Pubitemid 34764868)
27. I Tabas KJ Williams J Borén 2007 Subendothelial lipoprotein retention as the initiating process in atherosclerosis. Update and therapeutic implications Circulation 116 1832 1844 10.1161/CIRCULATIONAHA.106.676890 1:CAS:528:DC%2BD2sXhtFersLnL 17938300 (Pubitemid 350287108)
28. S Marcora F Casanova E Williams, et al. 2006 Preliminary evidence for cachexia in patients with well established ankylosing spondylitis Rheumatology (Oxford) 45 1385 1388 10.1093/rheumatology/kel127 1:STN:280: DC%2BD28nhslyiug%3D%3D (Pubitemid 44605474)
29. IL Engvall AC Elkan B Tengstrand T Cederholm K Brismar I Hafstrom 2008 Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor Scand J Rheumatol 37 5 321 328 10.1080/03009740802055984 1:CAS:528:DC%2BD1cXhtFOrtLfO 18666027
30. CH Hennekens 2000 Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 1767 1772 10769275
31. G Luc JM Bard I Juhan-Vague, et al. 2003 C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study Arterioscler Thromb Vasc Biol 23 55 1261 10.1161/01.ATV.0000079512.66448. 1D (Pubitemid 36871282)
32. JS Yudkin M Kumari SE Humphries V Mohamed-Ali 2000 Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148 209 214 10.1016/S0021-9150(99)00463-3 1:CAS:528:DC%2BD3cXosVymtw%3D%3D 10657556 (Pubitemid 30064452)
33. CJ Pepine 1998 Clinical implications of endothelial dysfunction Clin Cardiol 21 795 799 10.1002/clc.4960211103 1:STN:280:DyaK1M%2Fkt1Kgsw%3D%3D 9825190
34. JE Deanfield JP Halcox TJ Rabelink 2007 Endothelial function and dysfunction: testing and clinical relevance Circulation 115 10 1285 1295 17353456
35. P Ganz JA Vita 2003 Testing endothelial vasomotor function. Nitric oxide, a multipotent molecule Circulation 108 2049 2053 10.1161/01.CIR.0000089507. 19675.F9 14581383 (Pubitemid 37337576)
36. U Landmesser B Hornig H Drexler 2004 Endothelial function: a critical determinant in atherosclerosis? Circulation 109 suppl II II-27 II-33 10.1161/01.CIR.0000129501.88485.1f
37. ME Widlansky NL Gokce JF Keaney Jr JA Vita 2003 The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 1149 1160 10.1016/S0735- 1097(03)00994-X 1:CAS:528:DC%2BD3sXos1Wgur0%3D 14522472 (Pubitemid 37188333)
38. AC Langheinrich M Kampschulte T Buch RM Bohle 2007 Vasa vasorum and atherosclerosis-Quid novi? Thromb Haemost 97 6 873 879 1:CAS:528: DC%2BD2sXmvVWkur0%3D 17549287
39. A Amoroso F Del Porto C Di Monaco P Manfredini A Afeltra 1997 Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review Eur Rev Med Pharmacol Sci 1 17 25 1:STN:280:DyaK1c7gslantQ%3D%3D 9444794
40. SC Ballara JM Miotla EM Paleolog 1999 New vessels, new approaches:angiogenesis as a therapeutic target in musculoskeletal disorders Int J Exp Pathol 80 235 250 10.1046/j.1365-2613.1999.00129.x 1:CAS:528: DC%2BD3cXktFKm 10607014
41. Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D (2008) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis. 2008 Jul 14. [Epub ahead of print]
42. C Goldberger J Dulak C Duftner F Weidinger A Falkenbach M Schirmer 2002 Vascular endothelial growth factor (VEGF) in ankylosing spondylitis-a pilot study Wien Med Wochenschr 152 9-10 223 225 10.1046/j.1563-258X.2002.01118.x 1:STN:280:DC%2BD38zltFGltg%3D%3D 12094393 (Pubitemid 34596818)
43. M Drouart P Saas M Billot J-P Cedoz P Tiberghien D Wendling É Toussirot 2003 High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies Clin Exp Immunol 132 158 162 10.1046/j.1365-2249.2003.02101.x 1:CAS:528:DC%2BD3sXjtlKrsLY%3D 12653851 (Pubitemid 36418919)
44. HG Taylor JB Weiss B McLaughlin PT Dawes 1993 Raised endothelial cell stimulating angiogenesis factor in ankylosing spondylitis Clin Exp Rheumatol 11 5 537 539 1:STN:280:DyaK2c7gtFOmsg%3D%3D 7506131
45. PB Jones RJ Makki JB Weiss 1994 Endothelial cell stimulating angiogenesis factor-a new biological marker for disease activity in ankylosing spondylitis? Br J Rheumatol 33 4 332 335 10.1093/rheumatology/33.4.332 1:STN:280: DyaK2c3gslKqug%3D%3D 8156303
46. NA Karoli AP Rebrov 2007 Vascular wall lesion and disorder of endothelial vasoregulating function in patients with ankylosing spondylitis Klin Med (Mosk) 85 6 54 57 1:STN:280:DC%2BD2svmsVKhtA%3D%3D
47. DA Poddubny AP Rebrov 2007 Endothelial dysfunction in patients with Bechterew's disease (ankylosing spondylitis) Klin Med (Mosk) 85 7 66 69
48. F George C Brisson P Poncelet JC Laurent O Massot D Arnoux P Ambrosi C Klein-Soyer JP Cazenave J Sampol 1992 Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty Thromb Haemost 67 147 153 1:STN:280:DyaK38zhtFygtw%3D%3D 1615469
49. J Braun J Sieper M Breban E Collantes-Estevez J Davis R Inman, et al. 2002 Anti-tumournecrosis factor alpha therapy for ankylosing spondylitis: international experience Ann Rheum Dis 61 Suppl 3 iii51 iii60 1:CAS:528:DC%2BD38Xps1Krtr0%3D 12381511
50. J Gratacos A Collado X Filella R Sanmarti J Canete J Llena, et al. 1994 Serum cytokines(IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a closecorrelation between serum IL-6 and disease activity and severity Br J Rheumatol 33 10 927 931 10.1093/rheumatology/33.10.927 1:STN:280:DyaK2M%2FgsF2qsQ%3D%3D 7921752
51. S Dimmeler I Fleming B Fisslthaler C Hermann R Busse AM Zeiher 1999 Activation ofnitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 6736 601 605 10.1038/21224 1:CAS:528: DyaK1MXjvFegu7s%3D 10376603 (Pubitemid 29279182)
52. M Caliskan D Erdogan H Gullu S Yilmaz Y Gursoy A Yildirir, et al. 2008 Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis Atherosclerosis 196 1 306 312 10.1016/j.atherosclerosis.2006.11.003 1:CAS:528:DC%2BD1cXpt12jtQ%3D%3D 17169363
53. JY Choe MY Lee I Rheem MY Rhee SH Park SK Kim 2008 No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls Joint Bone Spine 75 5 548 553 10.1016/j.jbspin.2007.11.007 1:CAS:528:DC%2BD1cXhtlemsLjO 18487068
54. RT de Jongh RG Ijzerman EH Serne JJ Voordouw JS Yudkin HA de Waal, et al. 2006 Visceral and truncal subcutaneous adipose tissue are associated with impaired capillaryrecruitment in healthy individuals J Clin Endocrinol Metab 91 12 5100 5106 10.1210/jc.2006-1103 17003093 (Pubitemid 44917357)
55. RG Ijzerman JJ Voordouw MM van Weissenbruch JS Yudkin EH Serne HA Delemarrevande Waal, et al. 2006 TNF-alpha levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-alpha and insulin resistance Clin Sci (Lond) 110 3 361 368 10.1042/CS20050314 1:CAS:528:DC%2BD28XivV2mtbk%3D (Pubitemid 43341639)
56. J Wofford F Kahl G Howard W McKinney J Toole JI Crouse 1991 Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis Arterioscler Thromb 11 6 1786 1794 1:STN:280:DyaK38%2FjtFemug%3D%3D 1931880
57. I Sari T Okan S Akar H Cece C Altay M Secil M Birlik F Onen N Akkoc 2006 Impaired endothelial function in patients with ankylosing spondylitis Rheumatology 45 283 286 10.1093/rheumatology/kei145 1:STN:280: DC%2BD287gt1Sguw%3D%3D 16204374 (Pubitemid 43372841)
58. S Mathieu H Joly G Baron A Tournadre J-J Dubost J-M Ristori J-R Lusson M Soubrier 2008 Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease Rheumatology 47 1203 1207 10.1093/rheumatology/ken198 1:STN:280:DC%2BD1cvlsVOrsQ%3D%3D 18524805 (Pubitemid 352038227)
59. Pieringer H (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45(10):1319; author reply 1319-20. Comment on:Rheumatology (Oxford). 2006 Mar;45(3):283-286
60. M Galderisi S Cicala P Caso, et al. 2002 Coronary flow reserve andmyocardial diastolic dysfunction in arterial hypertension AmJ Cardiol 90 860 864 10.1016/S0002-9149(02)02708-X
61. D Erdogan H Gullu M Caliskan, et al. 2005 Coronary flow reserve in dipper and non-dipper hypertensive patients Blood Press 14 345 352 10.1080/08037050500356550 16403688 (Pubitemid 43135732)
62. van Eijk IC, Peters MJL, Serne EH, van der Horst-Bruinsma IE, Dijkmans BAC, Smulders YM, Nurmohamed MT (2008) Microvascular function is impaired in ankylosing spondylitis and improves after TNF blockade. Ann Rheum Dis 2008 Apr 4. [Epub ahead of print]
63. J Braun J Davis M Dougados J Sieper LS van der HD van der 2006 First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis Ann Rheum Dis 65 3 316 320 10.1136/ard.2005.040758 1:CAS:528:DC%2BD28XisFCjt7k%3D 16096329 (Pubitemid 43268219)
64. M Rudwaleit J Listing E Marker-Hermann, et al. 2004 Spinal mobility in early ankylosing spondylitis and in axial SpA without definite radiographic sacroillitis Ann Rheum Dis 63 Suppl 1 400